In recent years, there has been a significant rise in the interest and acceptance of psilocybin mushrooms across Canada.

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.

United Statescategory WHO makes last-ditch effort to keep America from leaving as Trump takes over January 18, 2025 ...